Dr. John Bell

Researcher

Recently, the foundation granted $500,000 to esteemed researcher Dr. John Bell of the Ottawa Hospital Research Institute in Canada to explore oncolytic viruses - man-made viruses that target only cancer cells.

In an accompanying editorial, cancer researcher John Bell, of the Ottawa Hospital Research Institute, in Ontario, Canada, wrote that the study provided "compelling evidence" that a single infusion of a modified virus could trigger a systemic anti-tumor response.

However, he wrote that a lot more research still needed to be done on oncolytic viruses, or OVs.

"We still know remarkably little about the best way to deliver OVs intravenously to patients," he wrote.